|
|
||||||||
Massachusetts General Hospital, Boston, Massachusetts
Correspondence: For reprints contact: Donald J. Hnatowich, Physics Research Laboratory, Massachusetts General Hospital, Boston, Mass. 02114.
ABSTRACT
Gallium-68 (T1/2 68 min) is a convenient label for radiopharmaceuticals designed for use with positron detection devices ; the radionuclide is a generator product obtained from its parent 68Ge (T1/2 287 days). The labeling procedure itself is simple since gallium forms complexes without the use of reducing agents. However, 68Ga is present in the generator eluant as the gallium-EDTA chelate and must be separated from EDTA prior to its use as a label. A rapid and efficient method for achieving this separation and for preparing 68Ga-labeled compounds for human use has been developed. Paper chromatography is employed to determine the amount of each major gallium species present in preparations of two gallium complexes; 68Ga-adenosine triphosphate and 68Ga-citrate.
This article has been cited by other articles:
![]() |
G. L. Brownell, T. F. Budinger, P. C. Lauterbur, and P. L. MCGeer Positron Tomography and Nuclear Magnetic Resonance Imaging Science, February 5, 1982; 215(4533): 619 - 626. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |